JPTCCM
IMMU

J.P. Turner & Co Capital Management’s Immunomedics Inc IMMU Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$428K Buy
248,625
+350
+0.1% +$893 0.44% 67
2015
Q2 		$1.01M Buy
248,275
+12,700
+5% +$51.9K 0.78% 34
2015
Q1 		$900K Buy
235,575
+68,000
+41% +$296K 0.83% 33
2014
Q4 		$805K Buy
+167,575
New +$662K 0.78% 32

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J.P. Turner & Co Capital Management's IMMU Position: Q3 2015 in Review

J.P. Turner & Co Capital Management increased its Immunomedics Inc (IMMU) stake by 0.14% in Q3 2015, buying an estimated $893 and bringing the position to 248,625 shares worth $428K. The position accounts for 0.44% of the portfolio, ranked #67.

J.P. Turner & Co Capital Management first reported a position in IMMU in Q4 2014 and has held it in 4 quarters since. The position peaked at $1.01M in Q2 2015. 79 funds tracked by Wall St. Rank hold IMMU as of Q3 2015.

  • J.P. Turner & Co Capital Management held 248,625 shares of Immunomedics Inc worth $428K as of Q3 2015.
  • J.P. Turner & Co Capital Management bought 350 Immunomedics Inc shares in Q3 2015, an estimated $893.
  • Immunomedics Inc made up 0.44% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #67 holding.
  • J.P. Turner & Co Capital Management first reported a position in Immunomedics Inc in Q4 2014 and has held it in 4 quarters since.
  • J.P. Turner & Co Capital Management's Immunomedics Inc position peaked at $1.01M in Q2 2015.
  • 79 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.